WFA
ABMD

Wipfli Financial Advisors’s Abiomed Inc ABMD Stock Holding History

Wipfli Financial Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$93K Buy
+378
New +$102K 0.01% 764

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Wipfli Financial Advisors's ABMD Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Abiomed Inc (ABMD) in Q3 2022: 378 shares worth $93K. The stake represents 0.01% of the portfolio and ranks #764 among its holdings.

517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • Wipfli Financial Advisors held 378 shares of Abiomed Inc worth $93K as of Q3 2022.
  • Abiomed Inc was a new Wipfli Financial Advisors position in Q3 2022.
  • Abiomed Inc made up 0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #764 holding.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.